Peptide Mechanism Maps
Each map summarises a major pathway that peptides discussed on this site interact with — receptor targets, downstream signalling, related peptides, related research stacks, and evidence caveats.
GH axis (GHRH / GHRP / IGF-1)
Hypothalamic-pituitary-GH signalling, downstream IGF-1, and the peptides that act on this axis.
Angiogenesis & VEGF / VEGFR2
How VEGF-mediated angiogenesis underlies tissue-repair claims for BPC-157 and TB-500.
NF-κB inflammation
The master inflammatory transcription factor, and the peptides claimed to modulate it.
AMPK & mitochondria
Energy-sensing kinase signalling and the mitochondrial peptides claimed to act there.
Melanocortin receptors (MC1R–MC5R)
Pigmentation, libido and energy homeostasis pathways acted on by melanocortin peptides.
Thymic / immune signalling
Thymalin, thymosin α-1 and related thymic-derived peptide claims.
Wound healing phases
Hemostasis → inflammation → proliferation → remodelling, and where peptides are claimed to act.
GLP-1 / GIP / glucagon receptors
Incretin receptor pharmacology, dual / triple agonist concepts, and regulatory sensitivity.